[Epidemiologic evaluation of the effectiveness of mass vaccination against mumps].
The effectiveness of mass immunization against mumps is evaluated with the use of data on 20 cities in the European part of the RSFSR. The expediency of using the indicator data on morbidity for many years in the preimmunization period for such evaluation is shown. These data permit the evaluation of the effectiveness of immunization for any month in the course of its carrying out. An essential decrease in mumps morbidity has been found to occur if immunization covered not less than 15-30% of children aged 1-14 years.
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control; D004341:Drug Evaluation; D006801:Humans; D007223:Infant; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control; D009108:Mumps Vaccine / Q000276:immunology*; D010507:Periodicity; D012426:Russia; D014505:Urban Population
D009108:Mumps Vaccine
Epidemiologicheskaia otsenka éffektivnosti massovoĭ vaktsinatsii protiv épidemicheskogo parotita.